Braun J, Baraliakos X, Deodhar AA, et al. Secukinumab Demonstrates Low Radiographic Progression and Sustained Efficacy through 4 Years in Patients with Active Ankylosing Spondylitis. ACR 2017, abstract 3L.
Risico op hart- en vaatziekten bij inflammatoire artritis verhoogd
jan 2024 | Arthritis psoriatica, RA, Spondyloartritis